Thrombocythemia Hemorrhagic

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-01-24
Clinical Trial Update: A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients [Phase 4]
Phase 4 trial update for anagrelide and hydroxyurea in high-risk essential thrombocythemia completed with results posted.